Q4 2023 · 13F-HR
Casdin Capital, LLCholdings as filed
Filed 2024-02-14 · accession 0000919574-24-001474
$1.02B
Reported value
38
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $163.9M | 16.1% | 5,714,775 | Common | SOLE |
| 09062W204 | BLFS | BIOLIFE SOLUTIONS INC | $141.5M | 13.9% | 8,707,165 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $97.1M | 9.53% | 1,006,500 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $81.3M | 7.98% | 7,387,943 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $44.5M | 4.37% | 1,091,867 | Common | SOLE |
| 45826J105 | NTLA | INTELLIA THERAPEUTICS INC | $44.2M | 4.34% | 1,450,000 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $43.6M | 4.28% | 313,000 | Common | SOLE |
| 92539P101 | — | VERVE THERAPEUTICS INC | $41.9M | 4.12% | 3,009,094 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $37.3M | 3.66% | 195,000 | Common | SOLE |
| 83444K105 | SLGCUSD | SOMALOGIC INC | $31.9M | 3.13% | 12,604,275 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $31.1M | 3.05% | 420,000 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $30.1M | 2.96% | 326,378 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $28.6M | 2.80% | 1,577,108 | Common | SOLE |
| 24823R105 | DNLI | DENALI THERAPEUTICS INC | $27.9M | 2.74% | 1,300,000 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $20.9M | 2.06% | 1,033,811 | Common | SOLE |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $20.7M | 2.03% | 6,381,377 | Common | SOLE |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $14.4M | 1.41% | 528,000 | Common | SOLE |
| 00288U106 | ABCL | ABCELLERA BIOLOGICS INC | $13.5M | 1.32% | 2,360,129 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $11.8M | 1.15% | 1,188,349 | Common | SOLE |
| 15673T100 | IPSC | CENTURY THERAPEUTICS INC | $10.6M | 1.04% | 3,206,380 | Common | SOLE |
| 05370A108 | RNAGBP | AVIDITY BIOSCIENCES INC | $10.6M | 1.04% | 1,175,750 | Common | SOLE |
| 64135M105 | NGNE | NEUROGENE INC | $10.2M | 1.00% | 524,616 | Common | SOLE |
| 69404D108 | PACB | PACIFIC BIOSCIENCES CALIF IN | $10.2M | 1.00% | 1,035,859 | Common | SOLE |
| 81663L200 | WGS | GENEDX HOLDINGS CORP | $8.5M | 0.84% | 3,095,511 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $7.7M | 0.75% | 2,050,000 | Common | SOLE |
| 192005106 | CDXS | CODEXIS INC | $6.1M | 0.60% | 2,000,000 | Common | SOLE |
| 901384107 | TSVT* | 2SEVENTY BIO INC | $5.0M | 0.50% | 1,182,623 | Common | SOLE |
| 00091E109 | ABSI | ABSCI CORPORATION | $4.1M | 0.40% | 973,260 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $3.5M | 0.34% | 25,000 | CALL | SOLE |
| 74168J101 | PRME | PRIME MEDICINE INC | $3.3M | 0.32% | 367,175 | Common | SOLE |
| 87164F105 | SNDX | SYNDAX PHARMACEUTICALS INC | $3.2M | 0.32% | 150,000 | Common | SOLE |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $2.9M | 0.28% | 510,882 | Common | SOLE |
| 34385P108 | LAB | STANDARD BIOTOOLS INC | $2.7M | 0.26% | 1,200,000 | Common | SOLE |
| 30223G102 | EXAIEUR | EXSCIENTIA PLC | $1.4M | 0.13% | 213,900 | Common | SOLE |
| 86366E106 | GPCR | STRUCTURE THERAPEUTICS INC | $1.0M | 0.10% | 25,000 | CALL | SOLE |
| 53000N108 | LIANY | LIANBIO | $922,675 | 0.09% | 206,415 | Common | SOLE |
| 82933R100 | — | SINGULAR GENOMICS SYSTEMS IN | $609,119 | 0.06% | 1,323,885 | Common | SOLE |
| 50107A104 | KRON1USD | KRONOS BIO INC | $154,799 | 0.02% | 123,839 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.